Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction to a voluntary recall of several brands of its enVista line of intraocular lenses that led to a ~5% decline in its stock in the previous session.

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 report from Global Data. The recall is associated with its enVista platform following a number of reports of toxic anterior segment syndrome cases by patients who had implanted enVista Envy IOLs,